Literature DB >> 24251727

Cluster of patients with Familial Mediterranean fever and heterozygous carriers of mutations in MEFV gene in the Czech Republic.

A Sedivá1, R Horváth, V Maňásek, A Gregorová, P Plevová, M Horáčková, M Tesařová, N Toplak, M Debeljak.   

Abstract

Familial Mediterranean fever (FMF) is a well-described monogenic autosomal recessive disorder with highest occurrence in the Mediterranean region. In this article, we describe the experience of a center in the Czech Republic that follows four families with members bearing mutations in MEFV gene without provable ancestry from the Mediterranean region. We also discuss the clinical picture of the heterozygous variants that were present in our cohort. The typical clinical presentation in heterozygotes corresponds to data described in the international literature. The possibility of combination of mutations and/or polymorphisms in different genes and epigenetic or environmental influences on the clinical symptoms are taken into account.
© 2013 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Familial Mediterranean fever; MEFV gene; amyloidosis; autoinflammatory syndromes; colchicine

Mesh:

Substances:

Year:  2013        PMID: 24251727     DOI: 10.1111/cge.12323

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  2 in total

1.  Prevalence of common MEFV mutations and carrier frequencies in a large cohort of Iranian populations.

Authors:  Maryam Beheshtian; Nasim Izadi; Gernot Kriegshauser; Kimia Kahrizi; Elham Parsi Mehr; Maryam Rostami; Masoumeh Hosseini; Maryam Azad; Mona Montajabiniat; Ariana Kariminejad; Stefan Nemeth; Christian Oberkanins; Hossein Najmabadi
Journal:  J Genet       Date:  2016-09       Impact factor: 1.166

2.  Adults with septic shock and extreme hyperferritinemia exhibit pathogenic immune variation.

Authors:  Kate F Kernan; Lina Ghaloul-Gonzalez; Bita Shakoory; John A Kellum; Derek C Angus; Joseph A Carcillo
Journal:  Genes Immun       Date:  2018-07-06       Impact factor: 2.676

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.